Clinical trial No longer in our active list Observational Ages 18 to 90

Validation of a new score for upper gastrointestinal bleeding in the emergency department

Official title: Validation of a New Tunisian Risk Score for Upper Gastrointestinal Bleeding in the Emergency Room: Study of the TU-GIB Score

Run by Hôpital Universitaire Sahloul · NCT05646433 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new scoring system to help doctors quickly identify patients with upper gastrointestinal bleeding who are at high risk for complications in emergency departments.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment500 (estimated)
SponsorHôpital Universitaire Sahloul
Academic / other
Locations1 site (Sousse)
Trial IDNCT05646433 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old presenting to the emergency department with non-traumatic upper gastrointestinal hemorrhage.

Probably not a fit

Patients under 18 years of age or those with lower gastrointestinal hemorrhage or external hemorrhoids will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to validate a newly developed clinical and biological score, the TU-GIB score, for patients presenting with upper gastrointestinal bleeding in emergency departments. The score is designed to identify patients at high risk for complications, allowing for better management strategies. It has shown improved predictive capabilities compared to the Glasgow-Blatchford score in terms of rebleeding, need for hemostasis therapy, and complications at 30 days. The study will involve multiple emergency departments to ensure external validation of the score.

Why it matters

Potential benefit: If successful, this score could enhance patient management and outcomes for those experiencing upper gastrointestinal bleeding.

How similar studies have gone: Previous studies have shown success with similar scoring systems, but this specific approach is novel and aims for external validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients consulting the emergency room for upper GI hemorrhage of non-traumatic origin.
* Age \>18 years

Exclusion Criteria:

* patient under the age of 18
* Lower gastrointestinal hemorrhag
* diagnosis of external hemorrhoids / perianal lesions
* Not consenting
* The lost sight

Where it's running

  • Sahloul University Hospital
    Sousse, Tunisia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.